What this record means
The record shows that XCELLDERMA is an abandoned application – the USPTO marked it “dead” after the applicant, Regenerex Pharma, Inc., failed to respond to an Office action, with the abandonment notice dated November 3 2026. The filing, made on December 5 2025, listed goods in International Class 5 covering medical and pharmaceutical preparations for wound care, including antiseptics, dressings and products aimed at healing or reducing odor in wounds, ulcers, burns and graft sites. Because the claim is limited to those pharmaceutical wound‑care items, a similar name used for unrelated products such as cosmetics, software or food would be farther from the scope shown here, though the record does not give the owner control over every possible use of the word. The prosecution history shows only the filing, an examiner assignment, a non‑final action in April 2026, an extension of time, and finally the abandonment; no oppositions, cancellations or court actions appear. I'd treat this as a meaningful concern if you plan a name in the same wound‑care pharmaceutical space.
Informational only - not legal advice.Goods & services
medical preparations, namely, wound care preparations; antiseptic preparations for medical, surgical and veterinary use; pharmaceutical preparations for wound care for application to necrotic wounds, ulcers, surgical wounds, burns, graft sites and cavity wounds; wound dressings; dressing materials for wounds, namely, medical pharmaceutical preparations for wound care in the nature of wound healing and wound care preparations and dressings; pharmaceutical preparations for wound care in the nature of wound healing and wound care preparations and dressings to help reduce wound odor; pharmaceutical preparations for wound care in the nature of wound healing and wound care preparations and dressings to help maintain an antiseptic wound healing environment